Machine Learning Identifies Ponatinib as a Potent Inhibitor of SARS-CoV2-induced Cytokine Storm
Preprint
Abstract
Although 15-20% of COVID-19 patients experience hyper-inflammation induced by massive cytokine production, cellular triggers of this process and strategies to target them remain poorly understood. Here, we show that the N-terminal domain (NTD) of the spike protein from the SARS-CoV-2 and emerging variants B1.1.7 and B.1.351 substantially induces multiple inflammatory molecules in human monocytes and PBMCs. Further, we identified several protein kinases, including JAK1, EPHA7, IRAK1, MAPK12, and MAP3K8, as essential downstream mediators of NTD-induced cytokine release. Additionally, we found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the NTD-mediated cytokine storm. Taken together, we propose that agents targeting multiple kinases required for the SARS-CoV-2-mediated cytokine storm, such as Ponatinib, may represent an attractive therapeutic option for treating moderate to severe COVID-19.Keywords
This publication has 10 references indexed in Scilit:
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic MutationImmunity, 2020
- Non-linear Deep Neural Network for Rapid and Accurate Prediction of Phenotypic Responses to Kinase InhibitorsiScience, 2020
- Preventing COVID-19-induced pneumonia with anticytokine therapyThe Lancet Rheumatology, 2020
- Baricitinib for COVID-19: a suitable treatment?The Lancet Infectious Diseases, 2020
- Structural basis of receptor recognition by SARS-CoV-2Nature, 2020
- THP-1 cells as a model for human monocytesAnnals of Translational Medicine, 2016
- Tissue-aware data integration approach for the inference of pathway interactions in metazoan organismsBioinformatics, 2014
- A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and MetastasisCell, 2014
- Exploiting polypharmacology for drug target deconvolutionProceedings of the National Academy of Sciences, 2014
- Model Selection Via Multifold Cross ValidationThe Annals of Statistics, 1993